Roche expands, adds jobs

Share this article:

Roche is taking on 500 new employees and is expanding its production capacity. The Swiss drug maker announced Monday that it was investing a total of $800 million across four locations over the next five years.

The company said in a statement that the expansions in Penzburg, Germany; Basel, Switzerland; and Vacaville and Oceanside, CA, are part of an efforts to support demand for biologics, such as Perjeta, as well as the antibody drug conjugate Kadcyla.

This may sound familiar: AstraZeneca announced Tuesday that, it, too was diving deeper into antibody drug conjugates through an acquisition and by purchasing an equity stake in an ADC-focused company.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.